AACR Features Cancer Center

Research by University of Illinois Cancer Center members, trainees, co-authors and others at the University of Illinois Chicago will be featured at the American Association for Cancer Research (AACR) 2024 Annual Meeting to be held April 5-10 in San Diego, California. A list of the abstracts is below.


1000 / 10 – Clinician and clinical trial staff perspectives on factors that impact enrollment of Black women in breast cancer trials

Christen Sandoval1, Eliza Brumer Cohn2, Leslie R. Carnahan3, Vida Henderson2, Tigist Mersha1, Neha Hippalgaonkar4, Joe Horowitz5, Sarah Khan6, Kauthar Salum2, Ana Williams3, Lolita Coleman7, Beluah Brent7, Anne Marie Murphy1, Paris Thomas8, Paramjeet Khosla6, Kent Hoskins3, Ryan Nguyen3
1School of Public Health, University of Illinois Chicago, Chicago, IL,2Fred Hutch Cancer Center, Seattle, WA,3University of Illinois Cancer Center, Chicago, IL,4Division of Hematology/Oncology, University of Illinois Chicago, Chicago, IL,5College of Medicine, University of Illinois Chicago, Chicago, IL,6Sinai Chicago, Chicago, IL,7Sisters Working It Out, Chicago, IL,8Equal Hope, Chicago, IL


2142 / 9 – Spatial distribution of high-risk human papillomavirus (HR-HPV) across 23 Chicago community areas and correlates

G. Goba1, J. Sun1, Q. Class1, J. Schwartz1, S. Kim1, K. Watson1, L. Tussing-Hummphreys1, Y. Molina1, S. MacLaughlan1, Z. Xu1, B. Aldred1, S. K. Kolar Rajanna1, T. Alexander1, A.-B. Moscicki2;
1University of Illinois Cancer Center, Chicago, IL, 2University of California, Los Angeles, Los Angles, CA


1301 / 15 – Comparing VA and safety-net hospital patient-reported care metrics and provider recommendations to address social determinants of health and demographics

N. Hippalgaonkar1, M. Weinfeld1, C. Weldon2, J. Trosman2, C. Chan3, S. Khan4, S. Paduri4, V. Reddy4, A. Sakhuja4, P. Khosla4, M. Pasquinelli1, L. Feldman1;
1University of Illinois at Chicago, Chicago, IL, 2Center for Business Models in Healthcare, Glencoe, IL, 3Jesse Brown VA Medical Center, Chicago, IL, 4Sinai Chicago, Chicago, IL


1496 / 9 – The role of endothelial ACKR1 in breast cancer metastasis

S. T. Roach, R. Patel, S. Thomas, C. Ewenighi-Amankwah, J. Dufraine, L. A. Naiche, J. Kitajewski;
University of Illinois at Chicago, Chicago, IL


3576 / 5 – CRISPR Cas9 mediated MADD deletion can induce autophagy via downregulation of MAPK and PI3K/AKT/mTOR signaling in anaplastic thyroid cancer

V. Bakthavachalam, M. Madhayan, M. Sanborn, J. Rehman, P. Bellur;
University of Illinois at Chicago, Chicago, IL


2770 / 28 – A novel MIRO2/MYO9B/RhoA signaling axis controls tumor cell invasion and metastasis

D. P. Boulton1, C. J. Hughes1, V. Vaira2, A. Jindal3, M. Raza1, S. Purdy1, S. Sant4, H. L. Ford1, M. Caino1;
1University of Colorado Anschutz Medical Campus, Aurora, CO, 2Università degli Studi di Milano, Milan, Italy, 3University of Pittsburgh, Pittsburgh, PA, 4University of Illinois Chicago, Chicago, IL


4806 / 23 – The potential impact of a Von Hippel-Lindau clinical care center for patients at the University of Illinois Chicago

N. Hippalgaonkar1, K. Drabek1, A. Aseem1, T. Maga1, L. Balay1, V. Pan1, P. Ganschow2, K. Tawagi1, N. Awati1, N. Reizine1;
1University of Illinois at Chicago, Chicago, IL, 2University of Illinois Cancer Center, Chicago, IL

6440 / 19 – Novel N-myristoyltransferase immunohistochemistry-based predictive and prognostic tests for breast cancer

A. Shrivastav1, D. Reddick1, A. Meher1, S. Varma Shrivastav2, S. Mittal1, V. K. Gadi3, L. Murphy4;
1The University of Winnipeg, Winnipeg, MB, Canada, 2Oncodrex Inc., Winnipeg, MB, Canada, 3University of Illinois Cancer Center, Chicago, IL, 4CancerCare Manitoba, Winnipeg, MB, Canada



CT286 / 16 – TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanoma

S. Thomas1, Y. K. Hong2, Y. Samhouri3, J. Larkin4, D. J. Olson5, G. K. In6, V. Atkinson7, P. Lammers8, A. J. S. Furness4, J. Martin-Liberal9, P. Terheyden10, A. S. Poklepovic11, R. H. Nguyen12, I. Peretz13, M. Butler14, A. Khattak15, L. Spain16, E. Gaughan17, M. Wilson18, J. W. Dubay19, A. Williams20, S. Goff21, G. C. Doolittle22, J. Chesney23, F. Finckenstein24, J. Chou24, X. Wu24, G. Sulur24, W. Shi24, J. Haanen25;
1Orlando Health, Orlando, FL, 2Cooper University Hospital, Camden, NJ, 3Allegheny Health Network Cancer Institute, Pittsburgh, PA, 4The Royal Marsden NHS Foundation Trust, London, United Kingdom, 5University of Chicago, Chicago, IL, 6University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, CA, 7Greenslopes Private Hospital, Greenslopes, Queensland, Australia, 8Baptist Cancer Center, Memphis, TN, 9ICO L’Hospitalet – Hospital Duran i Reynals, Barcelona, Spain, 10University of Lübeck, Lübeck, Germany, 11Virginia Commonwealth University, Richmond, VA, 12University of Illinois Hospital & Health Sciences System, Chicago, IL, 13Rabin Medical Center – PPDS, Beilinson, Israel, 14Princess Margaret Cancer Centre, Toronto, ON, Canada, 15Fiona Stanley Hospital & Edith Cowan University, Murdoch & Joondalup, Australia, 16Peter McCallum Cancer Centre, Melbourne, Australia, 17University of Virginia, Charlottesville, VA, 18St. Luke’s University Health Network, Division of Hematology Medical Oncology, Easton, PA, 19University of Alabama at Birmingham, O’Neal Comprehensive Cancer Center, Birmingham, AL, 20Sarah Cannon Research Institute SCRI, London, United Kingdom, 21National Cancer Institute, Bethesda, MD, 22University of Kansas Medical Center, Kansas City, KS, 23UofL Health Brown Cancer Center, University of Louisville, Louisville, KY, 24Iovance Biotherapeutics Inc, San Carlos, CA, 25Netherlands Cancer Institute & Leiden University Medical Center, Amsterdam & Leiden, Netherlands


6121 / 15 – Racial differences in the intratumoral immune cell infiltrate in luminal breast cancer

N. Hippalgaonkar1, G. Chlipala1, D. Huo2, G. Rauscher1, N. Adler1, J. Kitajewski1, K. Hoskins1;
1University of Illinois at Chicago, Chicago, IL, 2University of Chicago, Chicago, IL

6608 – Therapeutic enzyme depletion of L-serine for the treatment of serine auxotrophic tumors

Vipin Rawat1, Huiping Zhao1, Ladan Mashouri2, Prarthana Prasanth1, Kelly Conger1, Sarita Bhetawal2, Alessandra Araujo2, Everett Stone2, Jonathan Coloff1
1Physiology and Biophysics, University of Illinois College of Med. at Chicago, Chicago, IL,2University of Texas at Austin, Austin, TX


7366 / 23 – Loss of STK11 suppresses lipid metabolism to attenuate KRAS-induced immunogenicity in patients with non-small cell lung cancer

D. Principe1, M. Pasquinelli1, R. Nguyen1, L. Feldman1, A. Aissa2, F. D. Weinberg1;
1University of Illinois Chicago, Chicago, IL, 2Federal University of São Paulo, Sao Paulo, Brazil


7485 / 1 – Microfluidic detection of dual positive cells in whole blood of metastatic breast cancer patients J. Zhou, Q. Luan, C. Macaraniag, A. B. Guzman, M. Mantice, O. Danciu, K. F. Hoskins, I. Papautsky;
University of Illinois at Chicago, Chicago, IL


6682 / 13 – Bile acid profiles and racial disparities in colorectal cancer: Exploring the protective role of secondary bile acid derivatives

H. Dai1, P. G. Wolf2, L. Tussing-Humphreys3, E. Mutlu3, J. M. Ridlon1, R. Gaskins1;
1University of Illinois at Urbana-Champaign, Urbana, IL, 2Purdue University, West Lafayette, IN, 3University of Illinois at Chicago, Chicago, IL


444 / 22 – Lipid exposure re-wires cellular metabolism away from glycolysis toward the serine pathway conferring oncogenic properties to non-transformed breast cells

Mariana Bustamante Eduardo1, Gannon Cottone1, Shiyu Liu2, Flavio R. Palma1, Maria Paula Zappia3, Abul B.M.M.K. Islam3, Elizaveta V. Benevolenskaya3, Maxim V. Frolov3, Jason Locasale2, Marcelo G. Bonini1, Navdeep S. Chandel1, Seema Khan1, Susan Clare1
1Northwestern Univ. Feinberg School of Medicine, Chicago, IL,2Duke University, Durham, NC,3University of Illinois at Chicago, Chicago, IL


176 / 18 – Stearic acid induces pro-inflammatory macrophage response important for lung cancer development

A. Roy1, M. Davis1, S. Weinberg2, A. Mallisetty1, A. Hulbert1, F. D. Weinberg1;
1University of Illinois Chicago, Chicago, IL, 2Northwestern University, Chicago, IL


2319 / 30 – Deep learning-enabled dynamic infiltration and response to NK therapies in solid tumor organoids

L. Lonini1, S. Khare1, T. D. Lopez1, S. Szydlo1, M. Streit1, O. A. Karginova1, M. K. Flaherty1, A. Salahudeen2, A. Kunert3, A. Oja3, K. Sasser1, M. C. Stumpe1, C.-S. Ho1;
1Tempus Labs, Chicago, IL, 2University of Illinois Chicago, Chicago, IL, 3Sanofi, Amsterdam, Netherlands


6280 / 19 – Vitamin D enhances luminal differentiation of prostate organoids more than androgens

O. F. Cerna, Jr., L. Nonn, M. Schlicht, K. Krieger;
University of Illinois at Chicago, Chicago, IL


7649 / 10 – Inflammatory biomarkers by sarcopenia status in diverse individuals with lung cancer

C. A. Byrne1, G. Fantuzzi1, V. M. Oddo1, S. Kim1, T. J. Koh1, S. L. Gomez2;
1University of Illinois at Chicago, Chicago, IL, 2Rush University, Chicago, IL


7495 / 11 – Validation of microfluidic isolation of circulating pancreatic tumor cells from blood

C. Macaraniag, I. Khan, J. Zhou, P. C. Giulianotti, A. Borgeat, G. Votta-Velis, I. Papautsky;
University of Illinois at Chicago, Chicago, IL


3323 / 11 – Novel Pan-RAS inhibitor ADT-007: A unique mechanism of antitumor selectivity in pancreatic and colorectal carcinoma models J. Wang1, A. B. Keeton1, S. Ramesh1, P. Johnson1, Y. Y. Maxuitenko1, J. B. Foote2, C.-H. Huang1, K. L. Berry1, K. Fadlalla1, B. D. S. Reddy2, G. P. Nagaraju2, E. Nurmemmedov3, I. Babic3, V. Gaponenko4, X. Chen1, B. F. El-Rayes2, D. J. Buchsbaum2, G. A. Piazza1;
1Auburn University Harrison College of Pharmacy, Auburn, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Nerd Bio, San Diego, CA, 4University of Illinois Chicago, Chicago, IL


76 / 12 – Correlated multi-scale 3D optical microscopy of tumor tissues J. Zheng, S.-Y. Lee;
University of Illinois at Chicago, Chicago, IL


234 / 18 – Microfluidic chip for drug response studies in non-small cell lung carcinoma patient-derived organoids

Q. Luan, I. Pulido, A. Isagirre, J. Zhou, T. Shimamura, I. Papautsky;
University of Illinois Chicago, Chicago, IL


174 / 16 – Cholesterol efflux protein ABCA1 skews macrophages towards an anti-tumor phenotype and consequently impacts breast cancer progression

S. V. Bendre1, N. Krawczynska1, S. Bhogale1, E. Weisser1, S. Han1, B. Hajyousif1, A. Singh1, R. K C1, Y. Wang1, C. P. Schane1, A. T. Nelczyk1, A. DasGupta1, H. E. V. Gamage1, K. T. VanBortle1, E. Tajkhorshid1, S. Sinha2, W. Cho3, E. R. Nelson1;
1University of Illinois at Urbana-Champaign, Urbana, IL, 2Georgia Institue of Technology, Atlanta, GA, 3University of Illinois Chicago, Chicago, IL


1932 / 10 – Overcoming acquired resistance to KRAS(G12D) inhibition using a KRAS-HSP90 hetero-bifunctional small molecule therapeutic agent

I. Pulido Endrino1, L. gunder1, Q. Luan1, C. Ying2, Z. Yang2, J. Li2, Y. Wang2, Y. Sun2, C. Liu2, Y. Dai2, H. Zhou2, M. Massad1, I. Papautsky1, T. L. Prince3, G. Wang2, K. P. Foley3, W. Ying2;
1University of Illinois Chicago, Chicago, IL, 2RANOK Therapeutics, Hangzhou, China, 3RANOK Therapeutics, Waltham, MA


3771 / 27 – 3D correlated multi-scale cellular and molecular architecture of solid tumors

S.-Y. Lee1, Y.-C. Wu1, J. Zheng1, E. Khalil1, S. Wang2, A. Lippert3, J. Plank3;
1University of Illinois at Chicago, Chicago, IL, 2University of Chicago, Chicago, IL, 3Southern Methodist University, Dallas, TX


3772 / 28 – Tissue-niche-based and cell-type-selective in-depth proteomics

Y.-C. Wu1, E. Abi Khalil1, S. Weng2, S. Lee1;
1University of Illinois at Chicago, Chicago, IL, 2University of Chicago, Chicago, IL


4978 / 14 – Genomic characterization of metastatic pancreatic cancer according to tumor sample sites

S. Y. Goksu1, M. Ozer2, B. Bacik Goksu3, N. N. Sanford4, A. Jones4, N. Verma4, S. Kazmi4;
1West Suburban Medical Center, Oak Park, IL, 2Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 3University of Illinois at Chicago, Chicago, IL, 4UT Southwestern Medical Center, Dallas, TX


4979 / 15 – Genomic profiling of early-onset metastatic colorectal cancer based on tumor sample location

M. Ozer1, S. Y. Goksu2, B. Bacik Goksu3, N. N. Sanford4, A. Jones4, N. Verma4, S. Kazmi4;
1Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, 2West Suburban Medical Center, Oak Park, IL, 3University of Illinois at Chicago, Chicago, IL, 4UT Southwestern Medical Center, Dallas, TX


5740 / 8 – Peptide-functionalized dendrimers for enhanced binding to immune checkpoint proteins

P. A. Rawding1, F. Coppola2, D. Kim1, M. Poellmann1, D. Wheeler1, P. Král2, S. Hong1;
1University of Wisconsin-Madison, Madison, WI, 2University of Illinois at Chicago, Chicago, IL


6275 / 14 – Exposure to neighborhood violence rewires glucocorticoid receptor binding and drives proliferation and invasiveness in lung tumor samples

H. Heath1, J. Yoo1, V. Sharma1, H. McGee1, A. Soliman1, A. Mohamed2, A. K. Matthews3, R. Winn4, Z. Madak-Erdogan1, S. Kim5;
1University of Illinois at Urbana-Champaign, Champaign, IL, 2University of Illinois at Chicago, Chicago, IL, 3Columbia University, New York, NY, 4Virginia Commonwealth University, Richmond, VA, 5University of Illinois at Chicago, Champaign, IL


5247 / 22 – Reprogramming tumor microenvironment with intratumor macrophage adoptive cell therapy in melanoma

S. R. Noonepalle1, N. Gajendran1, M. Suresh1, X. Li1, M. D. G. Hernandez2, C. Z. Delgado3, N. Aghdam4, M. Berrigen5, T. Knox1, K. Tan1, M. Durr1, E. Sotomayor6, K. B. Chiappinelli2, D. Wardrop7, A. Horvath2, B. A. Shook2, N. H. Lee2, A. Dritschilo1, R. Fernandes2, K. Musunuri8, M. Shibata2, A. Villagra1;
1Georgetown University, Washington DC, DC, 2George Washington University, Washington DC, DC, 3University of Houston, Downtown, Houston, TX, 4Beth Israel Deaconess Medical Center, Boston, MA, 5George Wsahington University, Washington DC, DC, 6Tampa General Hospital, Tampa, FL, 7University of Illinois, Chicago, IL, 8Avstera Therapeutics Inc, Malvern, PA


LB453 / 29 – Distinct mechanism of CXCR7 activation in EGFR-mutated NSCLC by chemokines

L. C. Gunder1, I. Pulido1, J. H. Becker2, M. G. Massad1, T. Shimamura1;
1University of Illinois at Chicago, Chicago, IL, 2Northwestern University, Chicago, IL


7289 / 4 – PancreaAlert: Intelligent nanoengineered biosensor for pancreatic cancer

Meenal Karunanidhi1, Hemalatha Kanniyappan1, Edith Zhan2, Ruth Mathew3, Yani Sun3, Junyi Wu4, Yan Yan4, Gnanasekar Munirathinam1, Mathew T. Mathew1
1University of Illinois College of Medicine (Rockford), Rockford, IL,2Hononegah High School, Rockton, IL,3University of Illinois Chicago, Chicago, IL,4IIT, Chicago, IL


7306 / 21 – Licochalcone A is an excellent candidate for preventing luminal and non-luminal breast cancers

Atieh Hajirahimkhan1, Elizabeth T. Bartom1, Sriram Chandrasekaran2, Ruohui Chen1, Jeremy J. Johnson3, Susan E. Clare1, Seema A. Khan1
1Northwestern University – Chicago, Chicago, IL,2University of Michigan, Ann Arbor, MI,3University of Illinois Chicago, Chicago, IL

Translate »